281 related articles for article (PubMed ID: 29945887)
21. Dental considerations in the patient with Wilson's disease.
Lohe VK; Kadu RP; Degwekar SS; Bhowate RR; Wanjari AK; Dangore SB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):20-3. PubMed ID: 21176821
[TBL] [Abstract][Full Text] [Related]
22. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
23. Atp7b-/- mice as a model for studies of Wilson's disease.
Lutsenko S
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1233-8. PubMed ID: 19021531
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B.
Leng Y; Li P; Zhou L; Xiao L; Liu Y; Zheng Z; Qin F; Hao Q; Xu H; Yao S; Dong B
Hum Gene Ther; 2019 Dec; 30(12):1494-1504. PubMed ID: 31668086
[TBL] [Abstract][Full Text] [Related]
25. Wilson's disease.
Ferenci P
Clin Liver Dis; 1998 Feb; 2(1):31-49, v-vi. PubMed ID: 15560044
[TBL] [Abstract][Full Text] [Related]
26. Wilson's Disease: A Review for the General Pediatrician.
Capone K; Azzam RK
Pediatr Ann; 2018 Nov; 47(11):e440-e444. PubMed ID: 30423186
[TBL] [Abstract][Full Text] [Related]
27. Age-dependent changes of cerebral copper metabolism in Atp7b
Xie F; Xi Y; Pascual JM; Muzik O; Peng F
Metab Brain Dis; 2017 Jun; 32(3):717-726. PubMed ID: 28130615
[TBL] [Abstract][Full Text] [Related]
28. [Wilson's disease - a case report].
Karwowska K; Skrzypek J; Chabik G; Członkowska A; Zaborowska M; Wawrzyniak S
Pol Merkur Lekarski; 2016 Jan; 40(235):28-31. PubMed ID: 26891433
[TBL] [Abstract][Full Text] [Related]
29. Wilson's disease: Fatal when overlooked, curable when diagnosed.
Ferenci P; Ott P
J Hepatol; 2019 Jul; 71(1):222-224. PubMed ID: 31126728
[No Abstract] [Full Text] [Related]
30. [Wilson's disease].
Kovacević I; Zekan M
Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
[TBL] [Abstract][Full Text] [Related]
31. Clinical considerations for an effective medical therapy in Wilson's disease.
Weiss KH; Stremmel W
Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
[TBL] [Abstract][Full Text] [Related]
32. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.
Weiss KH; Askari FK; Czlonkowska A; Ferenci P; Bronstein JM; Bega D; Ala A; Nicholl D; Flint S; Olsson L; Plitz T; Bjartmar C; Schilsky ML
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):869-876. PubMed ID: 28988934
[TBL] [Abstract][Full Text] [Related]
33. The Specific Copper(II) Chelator TDMQ20 Is Efficient for the Treatment of Wilson's Disease in Mice.
Zhu Y; Tang Y; Huang L; Nguyen M; Liu Y; Robert A; Meunier B
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140060
[TBL] [Abstract][Full Text] [Related]
34. Hereditary iron and copper deposition: diagnostics, pathogenesis and therapeutics.
Aaseth J; Flaten TP; Andersen O
Scand J Gastroenterol; 2007 Jun; 42(6):673-81. PubMed ID: 17505988
[TBL] [Abstract][Full Text] [Related]
35. Wilson's disease: best practice.
Ryan A; Twomey PJ; Cook P
J Clin Pathol; 2023 Jul; 76(7):435-441. PubMed ID: 37045587
[TBL] [Abstract][Full Text] [Related]
36. Hepatic copper accumulation in a young cat with familial variations in the ATP7B gene.
Asada H; Kojima M; Nagahara T; Goto-Koshino Y; Chambers JK; Nakagawa T; Yokoyama N; Uchida K; Tsujimoto H; Ohno K
J Vet Intern Med; 2019 Mar; 33(2):874-878. PubMed ID: 30561139
[TBL] [Abstract][Full Text] [Related]
37. Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers.
Cheah DM; Deal YJ; Wright PF; Buck NE; Chow CW; Mercer JF; Allen KJ
Biometals; 2007 Oct; 20(5):751-7. PubMed ID: 17136311
[TBL] [Abstract][Full Text] [Related]
38. Chelating polymeric beads as potential therapeutics for Wilson's disease.
Mattová J; Poučková P; Kučka J; Skodová M; Vetrík M; Stěpánek P; Urbánek P; Petřík M; Nový Z; Hrubý M
Eur J Pharm Sci; 2014 Oct; 62():1-7. PubMed ID: 24815561
[TBL] [Abstract][Full Text] [Related]
39. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
Brewer GJ
Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118
[TBL] [Abstract][Full Text] [Related]
40. Wilson's disease: an update.
Das SK; Ray K
Nat Clin Pract Neurol; 2006 Sep; 2(9):482-93. PubMed ID: 16932613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
